A Study of INCB018424 Phosphate Cream in Subjects With Vitiligo

Status:
Active, not recruiting

Trial end date:
2021-09-30

Target enrollment:

Participant gender:

The purpose of this study will be to examine the efficacy, safety, and tolerability of ruxolitinib cream in subjects with vitiligo.

Phase 2

Incyte Corporation